World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
India Administers Price-Cap Dose to Drug Companies
Keywords:
India's National Pharmaceutical Pricing Authority placed pricing controls on frequently used antibiotics including Ciprofloxacin, diabetic drugs including Metformin, and heart medications. It also said it would audit manufacturers to ensure that normal production continues. The pricing authority acts under a 1955 law that requires pricing to be affordable for essential drugs needed by the vast majority of poor people in the country. Some mass consumption drugs are now imported where it is unprofitable to make them in India. In the case of other drugs the volume increases from lower prices increases access to medicines, and the volume makes up for the price cuts. An example cited by the pricing authority is essental antibiotic (especially for children), Augmentin, where the prices dropped by 40% but the volume increases as it became more affordable have more than made up for the price reductions, with overall sales higher than before the price cuts.
India's National Pharmaceutical Pricing Authority and pricing actions to keep drugs affordable, with increased access and sales making up for pricing cuts
09/22/2014
Grouped Articles
India Administers Price-Cap Dose to Drug Companies
Wall Street Journal 09/22/2014
Intellectual property issues, pricing and the Indian pharmaceutical industry
02/11/2012
Grouped Articles
India Administers Price-Cap Dose to Drug Companies
Wall Street Journal 09/22/2014
India-E.U. trade pact could boost AIDS treatment costs, health workers say - The Washington Post
Washington Post 02/11/2012
Indiaâs Supreme Court to Hear Dispute on Drug Patents
New York Times 03/06/2012
AARP Study Says Price of Popular Drugs Rose 26%
New York Times 03/06/2012
Top Court in India Rejects Novartis Drug Patent
New York Times 04/01/2013
Indian pharmaceutical companies and the growing demand in India.
02/09/2006
The rapidly growing Indian pharmaceutical companies. The Indian market $8 billion today will grow to $30 billion in the next 10 years as more people get access to better healthcare. Sales in the Middle East, Africa and Latin America, and outsourcing manufacture for western companies are additional sources of growth for these companies.
Grouped Articles
Looking East, Big Pharma Cuts Prices
BusinessWeek 04/15/2010
India Administers Price-Cap Dose to Drug Companies
Wall Street Journal 09/22/2014
Indian Drug Maker Vies for Betapharm
Wall Street Journal 02/09/2006
Economist 11/08/2007
India's Drug Firms May Boost a Healthy Portfolio
Wall Street Journal 12/17/2007
Indian Companies Hit Their Stride
BusinessWeek 09/17/2007
India's pharmaceutical industry and government price controls
10/09/2012
Grouped Articles
India Administers Price-Cap Dose to Drug Companies
Wall Street Journal 09/22/2014
India Looks To Expand Drug-Price Controls
Wall Street Journal 10/09/2012
Pharmaceutical product sales in emerging countries
04/15/2010
Sales of pharmaceutical products in Brazil, India, China, Russia and other emerging market countries as major pharmaceutical companies reduce prices to have broader access to these markets.
Grouped Articles
Looking East, Big Pharma Cuts Prices
BusinessWeek 04/15/2010
Abbott Looks to India for Shot in Arm
Wall Street Journal 08/26/2010
India Administers Price-Cap Dose to Drug Companies
Wall Street Journal 09/22/2014
China Worries Could Hurt Pharma’s Health
Wall Street Journal 08/24/2015
Chinese Market Offers New Life to Many Drugs
Wall Street Journal 03/30/2016
Indian pharmaceutical manufacturer Ranbaxy performance
03/06/2012
Grouped Articles
Generic-Drug Firms Go Beyond Knockoffs
Wall Street Journal 06/15/2013
Daiichi Sankyo to Sell Troubled Ranbaxy
Wall Street Journal 04/08/2014
India Administers Price-Cap Dose to Drug Companies
Wall Street Journal 09/22/2014
Indiaâs Supreme Court to Hear Dispute on Drug Patents
New York Times 03/06/2012
Generic Drug Makers Facing Squeeze on Revenue
New York Times 12/03/2012
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us